These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 29148290)

  • 1. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.
    Karami M; den Uil CA; Ouweneel DM; Scholte NT; Engström AE; Akin S; Lagrand WK; Vlaar AP; Jewbali LS; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):164-172. PubMed ID: 31353918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
    Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
    Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
    Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
    Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
    Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Impella CP insertion during cardiac arrest: A single center experience.
    Kamran H; Batra S; Venesy DM; Patten RD; Waxman S; Pyne C; Shah SP
    Resuscitation; 2020 Feb; 147():53-56. PubMed ID: 31891791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.